Your session is about to expire
← Back to Search
The Eleos Health Platform for Anxiety Disorders
N/A
Waitlist Available
Research Sponsored by Eleos Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
Study Summary
This trial will test if an AI platform can improve outcomes for adults receiving CBT for mental health issues. Patients & therapists will be surveyed to see if it's feasible & acceptable.
Eligible Conditions
- Anxiety Disorders
- Mood Disorders
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Generalized Anxiety Disorder-7 (GAD-7)
Patient Health Questionnaire-9 (PHQ-9)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: The Eleos Health PlatformExperimental Treatment1 Intervention
Therapists in the AI group will use the HIPAA-compliant, secure, password-protected Eleos Health platform. This AI tool was designed for behavioral health to support clinical decision-making and automation of administrative tasks. The platform captures the therapist and patient's utterances during a treatment session, analyzes the data, and offers feedback on the implementation of EBPs. The platform also incorporates a measurement-based care component, wherein standardized assessment scales completed by clients are immediately summarized and graphed for the therapist, who can use these data to inform therapy and share them with the patient. Insights and key indicators from the session data and MBC are summarized into a progress note draft which the therapist can then submit or edit as needed.
Group II: Treatment as UsualActive Control1 Intervention
Participants randomized to the control group will receive the routine services provided in the center. Therapists providing TAU will be permitted to use the strategies they deen would be most successful.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive behavioral therapy with AI
2021
N/A
~50
Find a Location
Who is running the clinical trial?
Missouri Department of Mental HealthUNKNOWN
Eleos HealthLead Sponsor
1 Previous Clinical Trials
280 Total Patients Enrolled
1 Trials studying Anxiety Disorders
280 Patients Enrolled for Anxiety Disorders
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there presently opportunities to partake in this medical experiment?
"According to information found on clinicaltrials.gov, this medical trial is not currently accepting participants; the study was first posted on September 1st 2021 and last updated on February 15th 2023. However, there are still 1261 other clinical trials open for enrollment at the moment."
Answered by AI
Share this study with friends
Copy Link
Messenger